Energisa S.A. (BVMF:ENGI3)

Inozyme Pharma Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	23,534	19,082	25,868	20,444	18,413	21,857
Market Cap Growth	-18.81%	-26.23%	26.53%	11.03%	-15.76%	3.88%
Enterprise Value	57,455	47,866	54,255	43,605	36,143	36,920
PE Ratio	6.89	5.04	13.66	9.57	7.11	16.02
PS Ratio	0.67	0.57	0.91	0.77	0.70	1.08
PB Ratio	1.03	0.86	1.65	1.64	2.03	2.98
P/FCF Ratio	56.46	12.39	11.87	25.79	-	8.18
P/OCF Ratio	3.80	2.64	3.87	3.60	20.88	4.55
EV/Sales Ratio	1.64	1.42	1.90	1.65	1.37	1.83
EV/EBITDA Ratio	6.68	5.69	7.12	6.23	6.16	9.85
EV/EBIT Ratio	8.70	7.31	8.97	7.62	7.81	14.31
EV/FCF Ratio	137.84	31.08	24.89	55.00	-	13.81
Debt / Equity Ratio	1.67	1.65	2.07	2.27	2.55	2.76
Debt / EBITDA Ratio	4.53	4.35	4.26	4.04	3.95	5.38
Debt / FCF Ratio	33.83	23.73	14.89	35.67	-	7.57
Quick Ratio	1.26	1.11	1.02	1.00	1.08	1.02
Current Ratio	1.38	1.23	1.12	1.11	1.27	1.12
Asset Turnover	0.46	0.46	0.45	0.47	0.53	0.48
Return on Equity (ROE)	21.50%	24.49%	18.32%	22.51%	33.72%	20.45%
Return on Assets (ROA)	5.42%	5.64%	5.92%	6.28%	5.81%	3.81%
Return on Capital (ROIC)	7.18%	7.66%	8.50%	9.79%	9.66%	6.31%
Return on Capital Employed (ROCE)	9.90%	10.50%	11.50%	12.30%	11.10%	7.80%
Earnings Yield	14.51%	19.86%	7.32%	10.45%	14.07%	6.24%
Earnings Yield	14.51%	19.86%	7.32%	10.45%	14.07%	6.24%
FCF Yield	1.77%	8.07%	8.43%	3.88%	-9.44%	12.23%
Dividend Yield	6.40%	5.42%	1.94%	3.02%	4.75%	1.89%
Payout Ratio	71.90%	42.12%	66.34%	74.07%	34.48%	22.21%
Buyback Yield / Dilution	-8.86%	-12.22%	-6.97%	-4.93%	-	-
Total Shareholder Return	-2.46%	-6.80%	-5.03%	-1.91%	4.75%	1.89%

Source: S&P Global Market Intelligence. Utility template. Financial Sources.